U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - August 2001

Approval Date Drug Name ANDA Number
8/2/01 FLUOXETINE ORAL SOLUTION, USP 20 MG/5 ML 75-506
8/2/01 FLUOXETINE CAPSULES, USP 20 MG 74-803
8/2/01 FLUOXETINE CAPSULES, USP 40 MG 75-465
8/2/01 FLUOXETINE HYDROCHLORIDE TABLETS 10 MG, AND 20 MG 75-755
8/2/01 FLUOXETINE CAPSULES, USP 10 MG 75-049
8/6/01 METIPRANOLOL OPHTHALMIC SOLUTION 0.3% 75-720
8/8/01 BUTORPHANOL TARTRATE NASAL SPRAY 10 MG/ML (1 MG/SPRAY); 2.5 ML METERED-DOSE SPRAY PUMP 75-759
8/17/01 TOBRAMYCIN FOR INJECTION, USP 1.2 G PHARMACY BULK PACKAGE 65-013
8/22/01 BUTALBITAL, ACETAMINOPHEN, CAFFEINE & CODEINE PHOSPHATE CAPS 50MG/325MG/40MG/30MG 74-911

 


totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: September 06, 200125 Apr 2006 08:54:28 -0400
Originator: OGC
HTML by PKS, TA